Aaron L. Zebolsky
University of California, San Francisco, Western Michigan University
Papers
2
Total Citations
29
H-Index
2
About
Aaron L. Zebolsky is a surgeon-scientist whose research focuses on refining treatment strategies for head and neck cancers, particularly oropharyngeal squamous cell carcinoma (OPSCC). His work centers on the intersection of transoral robotic surgery (TORS) and human papillomavirus (HPV)-positive disease, where he has made critical contributions to understanding postoperative risk stratification and functional outcomes. In his highly cited 2021 study on pathologic extranodal extension after TORS, Zebolsky demonstrated that patient-specific factors could predict adverse histopathologic features, enabling more personalized consultations and treatment planning for HPV-positive OPSCC patients. This work, with 21 citations, has helped surgeons better anticipate risks before primary surgery. He has also investigated the need for nasogastric tube feeding following TORS, providing evidence-based guidance on postoperative nutritional support that balances recovery with quality of life. By addressing both oncologic safety and functional preservation, Zebolsky’s research directly impacts clinical decision-making for one of the fastest-growing head and neck cancer populations. His contributions are particularly valuable for surgeons and oncologists seeking to optimize outcomes in the era of de-escalation therapy for HPV-positive disease.
Research Focus
Key Achievements
Top Papers
- 1
- 2